Steadman Philippon Research Institute
- Assets
- $15.7m
- Revenue
- $13.9m
- Investments
- $227.1k
- Employees
- 82
- Location
- Vail, CO
- Founding
- 12/1989
- Data as of
- 12/2023
- EIN
- 88-0245022
Organization Overview
Steadman Philippon Research Institute is located in Vail, CO. The organization was established in 1989. According to its NTEE Classification (H92) the organization is classified as: Biomedicine & Bioengineering Research, under the broad grouping of Medical Research and related organizations. As of 12/2023, Steadman Philippon Research Institute employed 82 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Steadman Philippon Research Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Steadman Philippon Research Institute generated $13.9m in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 0.8% each year. All expenses for the organization totaled $16.2m during the year ending 12/2023. While expenses have increased by 7.3% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
DEDICATION TO KEEPING PEOPLE PHYSICALLY ACTIVE THROUGH ORTHOPAEDIC RESEARCH AND EDUCATION.
Describe the Organization's Program Activity:
Part 3 - Line 4a
CENTER FOR REGENERATIVE AND PERSONALIZED MEDICINE (CRPM) - CRPM IS COMMITTED TO CONDUCTING THE HIGHEST IMPACT TEAM SCIENCE, LEVERAGING THE EXPERTISE OF THE INSTITUTE'S OTHER SCIENTIFIC DEPARTMENTS. CRPM'S KEY AREA OF FOCUS IS TO ACCELERATE CLINICAL TRANSLATION AND HELP SCIENTIFIC DISCOVERIES AND PROVEN TREATMENTS GET TO PATIENTS FASTER. CRPM'S SCIENTIFIC PROGRAMS INVESTIGATE CELLULAR SCIENCE AND REGENERATIVE MEDICINE TECHNIQUES AND THERAPIES. THESE PROGRAMS ARE: FRACTURE REPAIR AND REGENERATIVE THERAPEUTICS MUSCLE REPAIR AND STEM CELL BIOLOGY BONE AND CARTILAGE REPAIR AND STEM CELL BIOLOGY GENETIC AND CELLULAR ENGINEERING STEM CELL ENGINEERING AND CARTILAGE REGENERATION HEALTH AGING DIAGNOSTICS
SURGICAL SKILLS LABORATORY; EDUCATION AND FELLOWSHIP PROGRAM; DEPARTMENT OF TECHNOLOGY AND MULTIMEDIA COMMUNICATIONS, AND IMAGING RESEARCH
BIOMEDICAL ENGINEERING (BME) IS A MULTIDISCIPLINARY LABORATORY WHICH APPLIES QUANTITATIVE, ANALYTICAL, AND INTEGRATIVE METHODS TO THE FIELD OF ORTHOPAEDIC MEDICINE. THE MULTITALENTED RESEARCH STAFF INTEGRATES CLINICAL CARE, RESEARCH, AND EDUCATION WITH THE RESOURCES OF WORLD-RENOWNED MEDICAL DOCTORS IN ORDER TO IMPROVE THE TREATMENT OF MUSCULOSKELETAL DISEASES. THIS FOCUSED APPROACH IS DESIGNED TO MAINTAIN AND ENHANCE ATHLETIC PERFORMANCE, HEALTH, AND QUALITY OF LIFE FOR THE PROFESSIONAL, SEMI-PROFESSIONAL, COLLEGIATE, HIGH SCHOOL AND THE RECREATIONALLY ACTIVE INDIVIDUAL THROUGH AN EMPHASIS ON BENCH-TO-BEDSIDE RESEARCH. SEE CONTINUATION ON SCHEDULE O. THE PROGRAMS PROVIDED BY THE DEPARTMENT OF BIOMEDICAL ENGINEERING ARE UNIQUE AND DIVERSE AND THEY ENCOMPASS A COMPLETE RANGE OF SERVICES FOR THE PHYSICALLY ACTIVE OR THOSE WISHING TO RETURN TO AN ACTIVE LIFESTYLE AFTER INJURY.
THE CENTER FOR OUTCOMES-BASED ORTHOPAEDIC RESEARCH (COOR) PURSUES PATIENT-CENTERED OUTCOMES RESEARCH, WHICH HAS BEEN DEFINED AS THE STUDY OF THE END RESULTS OF MEDICAL TREATMENT, WHICH IS INTENDED TO PROVIDE SCIENTIFIC EVIDENCE TO SUPPORT PATIENT AND PHYSICIAN DECISIONS REGARDING MEDICAL TREATMENT. THE INSTITUTE'S OUTCOMES RESEARCH IS BASED ON PHYSICIAN/PATIENT ASSESSMENT OF IMPROVEMENT IN FUNCTION, QUALITY OF LIFE AND PATIENT SATISFACTION. OUTCOMES RESEARCH PROVIDES A TOOL TO LINK THE PATIENT'S PERSPECTIVE TO THE EFFECTIVENESS OF HEALTH TREATMENT. THIS ALLOWS FOR INCREASED PARTICIPATION BY PATIENTS IN THE DECISION-MAKING PROCESS REGARDING THE KIND OF CARE THEY DESIRE. OUR GOAL IN COOR IS TO LEARN FROM PATIENTS AND VALIDATE TREATMENT PROTOCOLS IN AN EFFORT TO IMPROVE THE QUALITY OF HEALTH CARE FOR EVERY PATIENT.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Eric Affeldt Board Member | Trustee | 1 | $0 |
Dan Drawbaugh Ceo/president | OfficerTrustee | 16 | $416,586 |
Stewart Turley Board Member | Trustee | 1 | $0 |
Gay L Steadman Board Member | Trustee | 1 | $0 |
Damaris Skouras Board Member | Trustee | 1 | $0 |
Mike Shannon Board Member | Trustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Cassidy & Associates Government Relations | 12/30/23 | $180,000 |
Robert Hardie Government Relations | 12/30/23 | $147,500 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $263,067 |
| Related organizations | $0 |
| Government grants | $2,280,320 |
| All other contributions, gifts, grants, and similar amounts not included above | $10,976,723 |
| Noncash contributions included in lines 1a–1f | $2,571,291 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $13,520,110 |
| Total Program Service Revenue | $250,367 |
| Investment income | $97,175 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $60,799 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | -$33,823 |
| Net Income from Fundraising Events | -$48,836 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $13,892,440 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $867,237 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $561,743 |
| Compensation of current officers, directors, key employees. | $561,743 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $6,970,480 |
| Pension plan accruals and contributions | $198,906 |
| Other employee benefits | $510,808 |
| Payroll taxes | $509,654 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $265,341 |
| Fees for services: Accounting | $57,790 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $17,970 |
| Fees for services: Other | $1,424,729 |
| Advertising and promotion | $232,884 |
| Office expenses | $339,754 |
| Information technology | $315,064 |
| Royalties | $0 |
| Occupancy | $567,219 |
| Travel | $474,098 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $68,727 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $513,070 |
| Insurance | $124,973 |
| All other expenses | $304,085 |
| Total functional expenses | $16,176,377 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $0 |
| Savings and temporary cash investments | $2,622,776 |
| Pledges and grants receivable | $2,613,434 |
| Accounts receivable, net | $1,482,173 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $143,944 |
| Net Land, buildings, and equipment | $1,228,203 |
| Investments—publicly traded securities | $270,435 |
| Investments—other securities | $227,050 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $7,153,978 |
| Total assets | $15,741,993 |
| Accounts payable and accrued expenses | $2,001,708 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $5,125,294 |
| Total liabilities | $7,127,002 |
| Net assets without donor restrictions | $992,671 |
| Net assets with donor restrictions | $7,622,320 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $15,741,993 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Lovelace Biomedical & Environmental Research Institute Inc Albuquerque, NM | $86,733,655 | $36,706,942 |
Steadman Philippon Research Institute Vail, CO | $15,741,993 | $13,892,440 |
Nebraska Educational Biomedical Research Association Omaha, NE | $3,597,352 | $983,373 |
Biomedical Research Foundation Of Southern Arizona Tucson, AZ | $383,333 | $237,867 |
Biomedical Research Foundation Of Colorado Denver, CO | $424,012 | $945 |